| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,349 |
22,594 |
$1.50M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
35,445 |
33,003 |
$1.31M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,317 |
3,909 |
$1.21M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,932 |
11,015 |
$437K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,825 |
8,216 |
$368K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27,697 |
16,557 |
$313K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
33,222 |
29,981 |
$258K |
| 80053 |
Comprehensive metabolic panel |
26,025 |
23,686 |
$246K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,267 |
10,184 |
$115K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,705 |
2,305 |
$110K |
| 87430 |
|
6,410 |
6,043 |
$98K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,183 |
2,962 |
$89K |
| 81001 |
|
19,922 |
18,065 |
$67K |
| 87088 |
|
6,803 |
6,169 |
$63K |
| 87081 |
|
5,479 |
5,170 |
$52K |
| 70450 |
Computed tomography, head or brain; without contrast material |
662 |
608 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
6,821 |
6,302 |
$35K |
| 71046 |
Radiologic examination, chest; 2 views |
3,644 |
3,425 |
$31K |
| 87807 |
|
2,353 |
2,243 |
$30K |
| 80061 |
Lipid panel |
1,940 |
1,837 |
$29K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
9,897 |
6,684 |
$29K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,641 |
1,543 |
$29K |
| 81025 |
|
8,898 |
7,994 |
$28K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,156 |
1,025 |
$24K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,113 |
997 |
$23K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
185 |
167 |
$22K |
| 87070 |
|
1,907 |
1,775 |
$21K |
| 83735 |
|
2,572 |
2,333 |
$18K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,513 |
1,443 |
$17K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
342 |
325 |
$17K |
| 84484 |
|
2,640 |
2,178 |
$17K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,273 |
1,140 |
$13K |
| 83690 |
|
2,102 |
1,915 |
$13K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,420 |
1,358 |
$13K |
| 84480 |
|
648 |
623 |
$12K |
| 84439 |
|
1,158 |
1,091 |
$12K |
| 83525 |
|
1,152 |
1,104 |
$12K |
| 83880 |
|
507 |
473 |
$11K |
| 83721 |
|
1,171 |
1,122 |
$8K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
27 |
25 |
$7K |
| 86762 |
|
356 |
311 |
$7K |
| 80305 |
|
794 |
720 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
91 |
81 |
$6K |
| 86803 |
|
358 |
314 |
$6K |
| 0002A |
|
162 |
156 |
$6K |
| 86592 |
|
1,119 |
991 |
$6K |
| 83655 |
|
344 |
325 |
$5K |
| 0001A |
|
180 |
170 |
$5K |
| 82607 |
|
249 |
238 |
$5K |
| 83605 |
|
597 |
513 |
$5K |
| 87340 |
|
361 |
313 |
$5K |
| 83020 |
|
286 |
248 |
$5K |
| 83021 |
|
280 |
248 |
$4K |
| 82550 |
|
797 |
682 |
$4K |
| 99233 |
Prolong inpt eval add15 m |
320 |
181 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
192 |
188 |
$3K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
40 |
40 |
$3K |
| 81003 |
|
1,172 |
958 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
116 |
101 |
$3K |
| 86850 |
|
455 |
386 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
518 |
455 |
$2K |
| 86140 |
|
1,200 |
1,106 |
$2K |
| 85610 |
|
554 |
511 |
$2K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
44 |
44 |
$2K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
57 |
57 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
173 |
142 |
$2K |
| 86900 |
|
513 |
436 |
$1K |
| 80076 |
|
207 |
175 |
$1K |
| 86901 |
|
513 |
436 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,981 |
1,787 |
$1K |
| 85027 |
|
271 |
258 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,448 |
3,047 |
$1K |
| 83540 |
|
124 |
121 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
30 |
27 |
$887.68 |
| 85730 |
|
442 |
401 |
$885.55 |
| 82948 |
|
279 |
246 |
$844.14 |
| 74022 |
|
44 |
39 |
$837.21 |
| 82077 |
|
104 |
94 |
$834.21 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
513 |
462 |
$826.99 |
| 85379 |
|
96 |
86 |
$709.24 |
| 82150 |
|
132 |
114 |
$661.74 |
| 84100 |
|
150 |
135 |
$595.80 |
| 93017 |
|
60 |
59 |
$561.20 |
| 85018 |
|
157 |
142 |
$468.45 |
| 85014 |
|
140 |
126 |
$416.40 |
| 83550 |
|
28 |
28 |
$374.34 |
| 84702 |
|
36 |
29 |
$364.56 |
| 72110 |
|
20 |
19 |
$318.36 |
| 84481 |
|
22 |
13 |
$271.92 |
| 87040 |
|
49 |
28 |
$262.86 |
| 59025 |
Fetal non-stress test |
77 |
61 |
$256.28 |
| 87186 |
|
32 |
29 |
$222.42 |
| 82728 |
|
15 |
15 |
$207.20 |
| 87077 |
|
32 |
29 |
$197.56 |
| 73562 |
|
13 |
12 |
$188.79 |
| 86800 |
|
21 |
12 |
$179.78 |
| 72050 |
|
14 |
13 |
$169.74 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
445 |
399 |
$127.32 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,774 |
4,269 |
$86.76 |
| 82465 |
|
12 |
12 |
$76.92 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
103 |
93 |
$66.62 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
13 |
$53.90 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16 |
15 |
$25.68 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
26 |
$19.76 |
| 93041 |
|
15 |
12 |
$17.79 |
| 36415 |
Collection of venous blood by venipuncture |
116 |
109 |
$4.48 |
| 80353 |
|
550 |
510 |
$0.00 |
| A9270 |
Non-covered item or service |
1,202 |
679 |
$0.00 |
| 80358 |
|
550 |
510 |
$0.00 |
| 80324 |
|
549 |
509 |
$0.00 |
| 80345 |
|
550 |
510 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
990 |
914 |
$0.00 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
260 |
239 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
129 |
117 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
169 |
147 |
$0.00 |
| 80361 |
|
550 |
510 |
$0.00 |
| 80346 |
|
550 |
510 |
$0.00 |
| 80365 |
|
550 |
510 |
$0.00 |
| 83992 |
|
550 |
510 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
58 |
50 |
$0.00 |